How long is it appropriate for the drug to act after affecting the cells before conducting transcriptome sequencing? What are the requirements for the samples?
When performing transcriptome sequencing after drug treatment, determining the duration of drug action and sample handling is crucial. It should be based on your experimental design and research objectives. Here are some suggestions:
1. Selection of Drug Action Duration
1. Choice of Time Points
The duration of drug action usually depends on the mechanism and target of the drug. Common time points include:
- Short-term (1-6 hours): Suitable for drugs with rapid responses, evaluating early gene expression changes.
- Mid-term (12-24 hours): Suitable for observing cellular adaptation or transcriptional regulation induced by the drug.
- Long-term (over 24 hours): Suitable for studying persistent effects, such as cell differentiation or growth inhibition.
2. Experimental Design
Experiments can be designed with multiple time points to comprehensively assess the drug's impact on the transcriptome.
2. Sample Requirements
1. Consistency of Cell State
Before drug treatment, ensure that all samples are in the same growth state (e.g., cell density, culture time) to avoid differences in cell state affecting transcriptome results.
2. Sample Collection After Drug Treatment
(1) Rapid Processing: After drug action, cells should be processed quickly to prevent changes in the transcriptome. Generally, cells are quickly washed with cold PBS to prevent non-specific gene expression.
(2) RNA Stability: When collecting cells, immediately add RNA stabilizers (such as RNAprotect or TRIzol) to prevent RNA degradation. If there are many samples, ensure consistent processing time for each batch when handling in batches.
3. RNA Quality Control
(1) RNA Extraction: Use appropriate reagents (such as TRIzol or column-based methods) to extract RNA, ensuring purity and integrity. The OD260/280 ratio of RNA samples should be between 1.8-2.0, indicating qualified sample purity.
(2) RNA Integrity: Use an Agilent 2100 Bioanalyzer or similar equipment to assess RNA quality, with RNA integrity number (RIN) ≥7 to ensure samples are suitable for transcriptome sequencing.
4. Biological Replicates
To ensure data reliability, at least three biological replicates (n=3) are required for each experimental condition to statistically analyze the significance of differential gene expression.
5. Setting Up Control Groups
In addition to the drug treatment group, be sure to set up a control group. The control group is typically untreated cells or cells treated with the drug solvent (such as DMSO) to eliminate gene expression changes caused by non-drug factors.
BiotechPack, A Biopharmaceutical Characterization and Multi-Omics Mass Spectrometry (MS) Services Provider
Related Services:
Prokaryotic Transcriptome Sequencing
How to order?
